Skip to main content

Bead-supported orthogonal colocalized proximity extension assay: multiplex protein detection toward early diagnostic applications for urolithiasis

Journal
Biosensors & bioelectronics (Q1)
Published
2 November 2026
Study design
Unclassified
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Zhiwei Jiang, Yuehan Yang, Qiushi He, Yanheng Huang, Dandan Zhou, Lvwen Zhang, et al.
PMID
43008453
DOI
10.1016/j.bios.2026.119390

Why clinicians should know about it

  • Picked for Biochemistry (medical) (paper of the day, 13 November 2026): Analytical validation of multiplex urinary protein assay

Abstract

Multiplexed, simple and rapid protein detection facilitates disease-related diagnostic workflows. Herein, we develop a bead-supported orthogonal colocalized proximity extension assay (Ort-CPEA) that enables fast, sensitive, one-pot quantification of three protein biomarkers for early-stage urolithiasis diagnosis. The colocalized PEA design accelerates target-protein recognition, yielding an observed kinetic rate constant 10-fold higher than that of conventional PEA. By integrating the Nt. BstNBI-driven DNA orthogonal reaction, our method achieves reliable multiplex protein detection. Ort-CPEA delivers superior analytical sensitivity for urolithiasis-associated protein markers, with limits of detection of 9.1 fg/mL for THP, 18.1 fg/mL for OPN, and 44.3 fg/mL for Fetuin-A, corresponding to an approximately 1000-fold sensitivity improvement over standard ELISA. Clinical urine-sample analysis validates the practical utility of Ort-CPEA for early urolithiasis diagnosis, yielding an area under the receiver-operating-characteristic curve (AUC) of 0.9900. This study presents a novel methodological tool for multiplex protein measurement and early-stage urolithiasis diagnosis.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.